BIOTECH company Ventus Medical, chaired by former OPSM boss Jonathan Pinshaw, has lodged a prospectus to raise $40 million and list on the Australian Securities Exchange.
The US-based medical device company claims its “proven” product can treat sufferers of sleep apnea, a sleeping disorder.
Ventus is asking investors for $3 a share, with expectations the company will list on the ASX by the end of next month.
